Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Annals of Hematology Année : 2020

Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC

Sylvain Chantepie
Edouard Forcade
Pascal Turlure
  • Fonction : Auteur
Fichier non déposé

Dates et versions

hal-02977222 , version 1 (24-10-2020)

Identifiants

Citer

Amandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, Regis Peffault de Latour, Didier Blaise, et al.. Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC. Annals of Hematology, 2020, 99 (8), pp.1855-1862. ⟨10.1007/s00277-020-04074-7⟩. ⟨hal-02977222⟩
81 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More